ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future

September 28, 1990

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

March 21, 2008

In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences

November 8, 2013

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995

First Oncology Nursing Certifications Exams Scheduled For April 30

November 8, 1985

DOD Funds 17 Ovarian Cancer Research Grants.

June 20, 2003